The American Journal of Managed Care® Launches ‘Understanding the Comorbidities: Psoriasis and Metabolic Syndrome’ Video Series

The expert “Peer Exchange” panel discusses the increased risk of developing metabolic syndrome in patients with psoriasis and the treatment options available

Download

Loading media player...

Joel Gelfand, M.D., MSCE, FAAD; Peter Dehnel, M.D.; and Steven Feldman, M.D., Ph.D., provide an overview of psoriasis, including diagnosis, genetic influence, and progression.

CRANBURY, N.J.--()--The American Journal of Managed Care® (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, presents its most recent “Peer Exchange” panel discussion, “Understanding the Comorbidities: Psoriasis and Metabolic Syndrome.” The video series features experts in the field of dermatology discussing psoriasis and metabolic syndrome and dissecting a variety of treatment options.

“Led by Dr. Peter L. Salgo, the panel of experts featured in this educational video series will provide an understanding of these comorbid conditions and discuss the causal relation between psoriasis and metabolic syndrome,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences™, parent company of AJMC®.

Here are the four distinguished experts on the panel:

  • Peter L. Salgo, M.D., professor of medicine and anesthesiology, Columbia University Vagelos College of Physicians and Surgeons and associate director of surgical intensive care, NewYork-Presbyterian Hospital, as moderator.
  • Peter J. Dehnel, M.D., medical director, Blue Cross affiliate in North Central United States.
  • Joel M. Gelfand, M.D., MSCE, FAAD, professor of dermatology and epidemiology; vice chair of clinical research and medical director, Dermatology Clinical Studies Unit; and director of the Psoriasis and Phototherapy Treatment Center, University of Pennsylvania Perelman School of Medicine.
  • Steven Feldman, M.D., professor of dermatology, Wake Forest School of Medicine.

The “Peer Exchange” begins with a conversation that defines both psoriasis and metabolic syndrome. The experts also discuss the burdens of psoriasis in addition to the role that genetics play in this chronic systemic inflammatory disease. Next the experts shift the conversation to discuss an understanding of the increased risk of developing metabolic syndrome for patients with psoriasis, highlighting their connectivity. The causal relation between the two conditions will be analyzed as the experts dive deeper into the biologics used to treat psoriasis and review their efficacy in patients who also present with metabolic syndrome.

For more information and to view the video series, click here.

About The American Journal of Managed Care®

The American Journal of Managed Care® (AJMC®) is a multimedia peer-reviewed, MEDLINE-indexed journal that keeps industry leaders on the forefront of health policy by sharing digital research relevant to industry decision-makers. Other brands in the AJMC® family include The American Journal of Accountable Care®, Evidence-Based Oncology™ and Evidence-Based Diabetes Management. These comprehensive multimedia brands bring together stakeholder views from payers, providers, policymakers and other industry leaders in managed care. AJMC® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in the U.S. dedicated to delivering trusted health care news across multiple channels.

Contacts

AJMC® Media:
Alexandra Ventura
609-716-7777, ext. 121
aventura@mjhassoc.com

Release Summary

The American Journal of Managed Care® Launches ‘Understanding the Comorbidities: Psoriasis and Metabolic Syndrome’ Video Series

Contacts

AJMC® Media:
Alexandra Ventura
609-716-7777, ext. 121
aventura@mjhassoc.com